You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

Select Your Country or Region
Send
COVID-19 Resource Center

Nyheter

Getinge to present additional information at Analyst meeting

Getinge to present additional information at Analyst meeting

Wayne, 3 February, 2009

Today, Getinge will hold an Analyst meeting in Wayne, New Jersey, USA, primarily aimed at providing an update on the Group’s increasing presence in the cardiovascular market.

Additional information about Getinge’s anticipated development will also be communicated at the meeting, including that sales for 2009 are expected to amount to approximately SEK 24 billion in the prevailing currency position and including Datascope. Getinge also announced that during the current year, the company will likely increase the Group’s target for EBITA margin for the period 2010 and onward. As announced earlier, the EBITA margin for the current year is expected to be in the range of 18 - 19%, which is also the Group’s current target.

Presentations from the Analyst meeting are available on Getinge’s website: (www.getingegroup.com).

Getinge AB (publ)

This information is such that Getinge AB is liable to publish in accordance with the Securities Markets Act and/or the Financial Instruments Trading Act.

Files

Del: